Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2012-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm201197zPMID 22191686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of peripheral versus spinal 5‐HT7 receptors in the modulation of pain undersensitizing conditions

  2012cited by this paper
• The 5‐HT7 receptor in learning and memory

  2012cited by this paper
• Mexiletine

  2012cited by this paper
• Antagonist interaction with the human 5‐HT7 receptor mediates the rapid and potent inhibition of non‐G‐protein‐stimulated adenylate cyclase activity: a novel GPCR effect

  2011cited by this paper
• Learning lessons from drugs that have recently entered the market.

  2011cited by this paper
• Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

  2011cited by this paper
• Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives

  2011cited by this paper
• Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors.

  2011cited by this paper
• Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy

  2011cited by this paper
• Hemodialysis as an alternative treatment of mexiletine intoxication.

  2011cited by this paper
• LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor.

  2010cited by this paper
• SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling.

  2010cited by this paper
• Molecular determinants of state‐dependent block of voltage‐gated sodium channels by pilsicainide

  2010cited by this paper
• 5‐HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice

  2009cited by this paper
• Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

  2009cited by this paper
• Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.

  2009cited by this paper
• 2008 FDA drug approvals

  2009cited by this paper
• (Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.

  2008cited by this paper
• Severe neonatal non‐dystrophic myotonia secondary to a novel mutation of the voltage‐gated sodium channel (SCN4A) gene

  2008cited by this paper
• Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.

  2008cited by this paper
• Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.

  2008cited by this paper
• Synthesis of (R)-, (S)-, and (RS) -hydroxymethylmexiletine, one of the major metabolites of mexiletine

  2007cited by this paper
• Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.

  2007cited by this paper
• N-dealkylation of arylpiperazine derivatives: disposition and metabolism of the 1-aryl-piperazines formed.

  2007cited by this paper
• Dechlorination of Aryl Chlorides with Sodium Formate Using a Homogeneous Palladium Catalyst

  2006cited by this paper
• Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents

  2006cited by this paper
• Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors.

  2006cited by this paper
• Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity.

  2006cited by this paper
• Myotonia congenita—a cause of muscle weakness and stiffness

  2006cited by this paper
• Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization.

  2005cited by this paper
• Systemic Administration of Local Anesthetics to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis

  2005cited by this paper
• Functional, molecular and pharmacological advances in 5-HT7 receptor research.

  2004cited by this paper
• Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.

  2004cited by this paper
• Studies on 1‐arylpiperazine derivatives with affinity for rat 5‐HT7 and 5‐HT1A receptors

  2004cited by this paper
• Stereospecific synthesis of "para-hydroxymexiletine" and sodium channel blocking activity evaluation.

  2004cited by this paper
• The price of innovation: new estimates of drug development costs.

  2003cited by this paper
• Synthesis and structure-affinity relationships of 1-[omega-(4-aryl-1-piperazinyl)alkyl]-1-aryl ketones as 5-HT(7) receptor ligands.

  2003cited by this paper
• Chiral switches.

  2000cited by this paper
• Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction

  2000cited by this paper
• Facile entry to (-)-(R)- and (+)-(S)-mexiletine.

  2000cited by this paper
• Clinical Pharmacokinetics of Mexiletine

  1999cited by this paper
• Voltage-gated ion channels and hereditary disease.

  1999cited by this paper
• Mexiletine as an adjuvant analgesic for the management of neuropathic cancer pain.

  1999cited by this paper
• Cloning, expression and pharmacology of a truncated splice variant of the human 5‐HT7 receptor (h5‐HT7(b))

  1997cited by this paper
• Synthesis and β-Adrenergic Activities of R-Fluoronaphthyloxypropanolamine

  1997cited by this paper
• Efficacy and Safety of Mexiletine in the Treatment of Painful Diabetic Neuropathy. The Mexiletine Study Group

  1997cited by this paper
• N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.

  1997cited by this paper
• Synthesis and beta-adrenergic activities of R-fluoronaphthyloxypropanolamine.

  1997cited by this paper
• Automated docking of flexible ligands: Applications of autodock

  1996cited by this paper
• Peripheral 5‐HT4 receptors

  1996cited by this paper
• Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum.

  1995cited by this paper
• Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

  1993cited by this paper
• Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.

  1991cited by this paper
• Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation.

  1991cited by this paper
• Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

  1990cited by this paper
• Effector coupling mechanisms of the cloned 5-HT1A receptor.

  1989cited by this paper
• Pharmacology and Clinical Use of Mexiletine

  1986cited by this paper
• Membrane changes in cells from myotonia patients.

  1985cited by this paper
• Metabolites of Cardiac Antiarrhythmic Drugs: Their Clinical Role

  1984cited by this paper
• The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products

  1981cited by this paper
• alpha-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites.

  1980cited by this paper
• Evaluations on New Drugs

  1979cited by this paper
• Rapid chromatographic technique for preparative separations with moderate resolution

  1978cited by this paper
• The clinical pharmacology of mexiletine.

  1978cited by this paper
• The identification and analysis of mexiletine and its metabolic products in man

  1977cited by this paper
• The distribution, metabolism and excretion of mexiletine in man.

  1977cited by this paper
• The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material.

  1949cited by this paper
• THE FATE OF ACETOPHENETIDIN (PHENACETIN) IN MAN AND METHODS FOR THE ESTIMATION OF ACETOPHENETIDIN AND ITS METABOLITES IN BIOLOGICAL MATERIAL

  1949cited by this paper

• Pharmacogenetic pilot study of CYP2D6 and CYP1A2 genes in Italian patients with non-dystrophic myotonia and myotonic dystrophy treated with mexiletine.

  2025cites this paper
• Expanding the Role of Chiral Drugs and Chiral Nanomaterials as a Potential Therapeutic Tool.

  2024cites this paper
• Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs

  2023cites this paper
• Hexaazatrinaphthalene-Based Covalent Triazine Framework-Supported Rhodium(III) Complex: A Recyclable Heterogeneous Catalyst for the Reductive Amination of Ketones to Primary Amines.

  2023cites this paper
• The Influence of Law Enforcement, The Role of Parents in Tackling Juvenile Delinquency Concuming Drugs in Sukabumi District

  2023cites this paper
• Phosphine-Based Hyper-Cross-Linked Polymer-Supported Neutral Gold(I) Complex as a Recyclable Catalyst for the Regioselective Hydration of Alkynes to Ketones

  2022cites this paper
• Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease

  2022cites this paper
• A Look at the Importance of Chirality in Drug Activity: Some Significative Examples

  2022cites this paper
• Voltage Gated Sodium Channel Blockers: Synthesis of Mexiletine Analogues and Homologues.

  2020cites this paper
• Synthesis and Evaluation of Voltage‐Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities

  2020cites this paper
• Advances in Synthesis and Medicinal Applications of Compounds Derived from Phthalimide.

  2020cites this paper
• SYNTHESIS, CHARACTERIZATION, AND ANTHELMINTIC ACTIVITY OF NOVEL BENZOTHIAZOLE DERIVATIVES CONTAINING INDOLE MOIETIES

  2019cites this paper
• Stereoselective Modulation of P‐Glycoprotein by Chiral Small Molecules

  2016cites this paper
• Antiproliferative Activity Evaluation of a Series of N-1,3-Benzothiazol-2-ylbenzamides as Novel Apoptosis Inducers

  2016cites this paper
• Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels.

  2016cites this paper
• X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors.

  2016cites this paper
• Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues.

  2016cites this paper
• Antiarrhythmic Mexiletine: A Review on Synthetic Routes to Racemic and Homochiral Mexiletine and its Enantioseparation.

  2016cites this paper
• 1, 3‐Benzothiazoles as Antimicrobial Agents

  2015cites this paper
• Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells.

  2015cites this paper
• Mexiletine metabolites: a review.

  2015cites this paper
• Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine

  2015cites this paper
• Molar efficiency : a useful metric to gauge relative reaction efficiency in discovery medicinal chemistry

  2014cites this paper
• New titanocene derivatives with high antiproliferative activity against breast cancer cells.

  2014cites this paper
• N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels.

  2014cites this paper
• Data mining methods for the prediction of intestinal absorption using QSAR

  2014cites this paper
• L-1416, a novel MDR reversing agent with possible reduced calcium antagonism

  2014cites this paper
• Combined modifications of mexiletine pharmacophores for new lead blockers of Na(v)1.4 channels.

  2013cites this paper
• N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.

  2013cites this paper
• Stereospecific synthesis of m-Hydroxymexiletine enantiomers.

  2013cites this paper
• Capillary zone electrophoresis for separation and quantitative determination of mexiletine and its main phase I metabolites.

  2013cites this paper
• Searching for new antiarrhythmic agents: evaluation of meta-hydroxymexiletine enantiomers.

  2013cites this paper
• 2-Aminobenzothiazole derivatives: search for new antifungal agents.

  2013cites this paper